Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Type I interferons play a key role in the development of various skin diseases.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Baricitinib successfully treated severe hair loss.